The permanent injunction requires the defendants to cease manufacturing, holding, or distributing dietary supplements until they hire an independent expert to ensure that they are following the CGMP regulations, and, following an inspection, receive the FDA’s approval to resume operations. Among the violations outlined in the release:
- The defendants violated the FD&C Act because their products were prepared, packed, or held in violation of the Current Good Manufacturing Practice (CGMP) regulations for dietary supplements.
- Multiple FDA inspections showed that the defendants repeatedly failed to verify the identity of each dietary ingredient used in the manufacture of their supplements.
- The defendants failed to verify that their products met specifications for purity, strength, composition, and contamination limits.